These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25539584)

  • 1. Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery.
    Besic V; Stubbs RS; Hayes MT
    BMC Gastroenterol; 2014 Dec; 14():222. PubMed ID: 25539584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
    Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant liver insulin receptor isoform a expression normalises with remission of type 2 diabetes after gastric bypass surgery.
    Besic V; Shi H; Stubbs RS; Hayes MT
    PLoS One; 2015; 10(3):e0119270. PubMed ID: 25742416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitivity is related to glycemic control in type 2 diabetes and diabetes remission after Roux-en Y gastric bypass.
    Gavin TP; Ernst JM; Caudill SE; Dohm GL; Pories WJ; Dar M; Reed MA
    Surgery; 2014 Jun; 155(6):1036-43. PubMed ID: 24856123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
    Martinussen C; Bojsen-Møller KN; Dirksen C; Jacobsen SH; Jørgensen NB; Kristiansen VB; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E535-44. PubMed ID: 25628424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.
    Reed MA; Pories WJ; Chapman W; Pender J; Bowden R; Barakat H; Gavin TP; Green T; Tapscott E; Zheng D; Shankley N; Yieh L; Polidori D; Piccoli SP; Brenner-Gati L; Dohm GL
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2525-31. PubMed ID: 21593117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.
    Yan Y; Zhou Z; Kong F; Feng S; Li X; Sha Y; Zhang G; Liu H; Zhang H; Wang S; Hu C; Zhang X
    Obes Surg; 2016 Nov; 26(11):2683-2690. PubMed ID: 27038047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of obestatin in roux-en-Y gastric bypass-induced remission of type 2 diabetes mellitus.
    Wang JL; Xu XH; Zhang XJ; Li WH
    Diabetes Metab Res Rev; 2016 Sep; 32(6):470-7. PubMed ID: 26445403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals.
    Maranghi M; Prudente S; D'Erasmo L; Morini E; Ciociola E; Coletta P; Verrienti A; Arciello S; Copetti M; Pellegrini F; Santini SA; Morano S; Filetti S; Trischitta V
    Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):505-10. PubMed ID: 22402064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of type 2 diabetes after Roux-en-Y gastric bypass or sleeve gastrectomy is associated with a distinct glycemic profile.
    Jiménez A; Ceriello A; Casamitjana R; Flores L; Viaplana-Masclans J; Vidal J
    Ann Surg; 2015 Feb; 261(2):316-22. PubMed ID: 25569030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action: GALNT2: a novel modulator of insulin signaling.
    Marucci A; Cozzolino F; Dimatteo C; Monti M; Pucci P; Trischitta V; Di Paola R
    Biochim Biophys Acta; 2013 Jun; 1833(6):1388-95. PubMed ID: 23500900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN; Dirksen C; Jørgensen NB; Jacobsen SH; Serup AK; Albers PH; Hansen DL; Worm D; Naver L; Kristiansen VB; Wojtaszewski JF; Kiens B; Holst JJ; Richter EA; Madsbad S
    Diabetes; 2014 May; 63(5):1725-37. PubMed ID: 24241533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery.
    Lund MT; Hansen M; Skaaby S; Dalby S; Støckel M; Floyd AK; Bech K; Helge JW; Holst JJ; Dela F
    J Physiol; 2015 Jul; 593(14):3123-33. PubMed ID: 25867961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.